引用次数
引用: 2,099
H-指数: 28
I10-指数 : 38
出版物: 65
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
Ingrid Quist-Løkken , Clara Andersson-Rusch , Martin Haugrud Kastnes , Jürgen Markus Kolos
Cell Communication and Signaling 21 ( 1) 25 -25
4
2023
P-364 Novel FKBP12 targeting PROTACs enhances BMP-induced apoptosis in multiple myeloma
Ingrid Quist-Lokken , Michael Walz , Felix Hausch , Toril Holien
Clinical Lymphoma Myeloma and Leukemia 23 S240 -S240
2023
Targeting FKBP12 enables bone morphogenetic proteins to kill multiple myeloma cells via ALK2
Ingrid Quist-Løkken , Clara Andersson-Rusch , Martin Haugrud Kastnes , Jürgen Markus Kolos
2023
Receptor binding competition: A paradigm for regulating TGF-β family action
Erik Martinez-Hackert , Anders Sundan , Toril Holien
Cytokine & growth factor reviews 57 39 -54
63
2021
Modification of extracorporeal photopherisis technology with porphyrin precursors
Qian Peng , Trond Warloe , Jahn M Nesland , Eidi Christensen
2020
GDF15 promotes osteoclast differentiation, inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease
Marita Westhrin , Siv Helen Moen , Toril Holien , Anne Kærsgaard Mylin
2015
MYC gene copy number determine MYC expression and sensitivity to a MYC-inhibitor in multiple myeloma cells
Toril Holien , Kristine Misund , Glenn Buene , Oddrun E Olsen
Cancer Research 74 ( 19_Supplement) 2351 -2351
2014
Dependency on c-MYC in multiple myeloma.
Toril Holien , Thea K Våtsveen , Hanne Hella , Anders Waage
Cancer Research 73 ( 8_Supplement) 3130 -3130
2013
A novel APIM-motif comprising peptide drug potentiates the action of several chemotherapeutic drugs by blocking the interaction between PCNA and key proteins involved in DNA repair, apoptosis and cell cycle control
Marit Otterlei , Rebekka Muller , Toril Holien , Siri Backhe
Cancer Research 72 ( 8_Supplement) 4676 -4676
2012
Application of photodynamic therapy with 5-aminolevulinic acid to extracorporeal photopheresis in the treatment of patients with chronic graft-versus-host disease: A first-in-human study
Eidi Christensen , Olav A Foss , Petter Quist-Paulsen , Ingrid Staur
Pharmaceutics 13 ( 10) 1558 -1558
7
2021
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study
Eidi Christensen , Olav Andreas Foss , Toril Holien , Petras Juzenas
Pharmaceutics 16 ( 6) 815 -815
2024
Research Article Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, AndosanC
Jon-Magnus Tangen , Toril Holien , Mohammad Reza Mirlashari , Kristine Misund
2017
The oncogenic role of PRL-3 in multiple myeloma through regulation of Src kinase family members
Pegah Abdollahi , Esten Nymoen Vandsemb , Magnus Aassved Hjort , Kristine Misund
Cancer Research 76 ( 14_Supplement) 196 -196
2016
GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels are Associated with Multiple Myeloma Bone Disease
M. Westrin , S.H. Moen , T. Holien , O.E. Olsen
Clinical Lymphoma, Myeloma & Leukemia 15
2015
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease
M. Westhrin , S. H. Moen , T. Holien , A. K. Mylin
Haematologica 100 ( 12) 511 -514
17
2015
CpG-ODN inhibits Smad-dependent BMP signaling; Effects on myeloma cell apoptosis and in vitro osteoblastogenesis
N. Nørgaard , T. Holien , S. Jönsson , H. Hella
Bone 48 ( 1)
2011
HGF - c-Met interaction with syndecan-1 in lipid rafts promotes Akt signaling in myeloma cells
M Majka , H Hov , A Sundan , M Børset
2013
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.
Oddrun Elise Olsen , Karin Fahl Wader , Kristine Misund , Thea Kristin Våtsveen
Blood Cancer Journal 4 ( 3) 196 -196
27
2014
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
K K Starheim , T Holien , K Misund , I Johansson
Blood Cancer Journal 6 ( 7)
28
2016
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
U-M Fagerli , K Ullrich , T Stühmer , T Holien
Oncogene 30 ( 28) 3198 -3206
52
2011